Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesGender-Affirming CareJohns Hopkins EHP Gender‑Affirming Coverage & Prio…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Currentjohns_hopkins_health_plansPolicy CMS24.08

    Gender‑Affirming Treatment & Procedures - EHP

    Customize your policy alerts

    Sign up for johns_hopkins_health_plans Policy CMS24.08 alerts

    Get alerted when Policy CMS24.08 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs authorization and coverage criteria for gender-affirming medical and surgical treatments and adjunctive procedures for members of Johns Hopkins Employer Health Programs (EHP). It describes diagnostic requirements, age-specific criteria, covered procedures, exclusions, and related considerations (e.g., fertility, hormones).

    Policy Summary
    Payerjohns_hopkins_health_plans
    PolicyGender‑Affirming Treatment & Procedures - EHP
    Policy CodePolicy CMS24.08
    Change TypeNo material clinical or coverage changes
    Effective DateApr 1, 2026
    Last ReviewJan 20, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit a referral/letter of medical necessity documenting DSM-5-TR diagnostic criteria, duration, informed consent capacity, reproductive counseling, and multidisciplinary assessments as required for surgical authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    18+Minimum age for most adult surgical coverage
    12m / 6mHormone therapy duration required
    WPATH SOC-8Primary clinical guidance cited
    ~80+Procedure codes enumerated
    04/01/2026Policy effective

    Coverage Criteria for Gender-Affirming Care

    Diagnosis of Gender Dysphoria (Adolescents and Adults)

    Covered when ALL of the following DSM-5-TR diagnostic criteria are met

    DSM-5-TR diagnostic criteria: Marked incongruence between one's experienced/expressed gender and sex assigned at birth for at least 6 months, as manifested by at least TWO of the following indicators:duration >= 6 months; at least two indicators

    Indicators include: (i) incongruence with primary/secondary sex characteristics (or anticipated characteristics in young adolescents); (ii) strong desire to be rid of primary/and/or secondary sex characteristics or to prevent their development; (iii) strong desire for the primary/and/or secondary sex characteristics of another gender; (iv) strong desire to be of another gender; (v) strong desire to be treated as another gender; (vi) strong conviction of having the typical feelings/reactions of another gender.

    Associated distress or impairment: The condition is associated with clinically significant distress or impairment in social, occupational, or other important areas of functioning.

    Adult Surgical Eligibility (Breast/Chest/Genital/Adjunctive Surgery)

    Policy Summary
    Payerjohns_hopkins_health_plans
    PolicyGender‑Affirming Treatment & Procedures - EHP
    Policy CodePolicy CMS24.08
    Change TypeNo material clinical or coverage changes
    Effective DateApr 1, 2026
    Last ReviewJan 20, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization and submit a referral/letter of medical necessity documenting DSM-5-TR diagnostic criteria, duration, informed consent capacity, reproductive counseling, and multidisciplinary assessments as required for surgical authorization.
    SourceLink
    On This Page
    Coverage Criteria for Gender-Affirming CareCoding: CPT, HCPCS and Diagnosis CodesProvider Actions, Authorization & DocumentationBackground and ScopeDefinitions and Key TermsRevision History

    Covered when ALL of the following are met

    Age requirement: Member is 18 years of age or older.
    Referral / Letter of Medical Necessity: A letter of referral from a qualified licensed healthcare professional that: confirms the member meets diagnostic criteria for gender dysphoria/incongruence; documents that gender dysphoria/incongruence is marked and sustained over time; demonstrates capacity to make fully informed decisions and consent for the specific surgical intervention; documents understanding of effects on reproduction and that reproductive options have been explored; identifies and excludes other possible causes of apparent gender dysphoria/incongruence; assesses mental health and physical conditions that could negatively impact surgical outcome and discusses risks and benefits.
    Hormone therapy for gonadectomy: For individuals seeking gonadectomy, six months of gender-affirming hormone therapy (or longer if required to achieve desired surgical result) is required unless hormone therapy is not desired or is medically contraindicated.>= 6 months hormone therapy unless not desired or contraindicated

    Policy allows exception if hormone therapy is not desired or is medically contraindicated.

    Adolescent Surgical Eligibility

    Covered on case-by-case basis when ALL of the following are met

    Comprehensive assessment: A comprehensive biopsychosocial assessment by qualified licensed mental health AND medical professionals has been completed.
    Referral / Letter of Medical Necessity (adolescents): A letter of referral from a qualified licensed healthcare professional that: confirms diagnostic criteria are met; documents that gender dysphoria/incongruence is marked and sustained; demonstrates capacity, emotional and cognitive maturity required to provide informed consent/assent for the specific surgical intervention; documents understanding of reproductive effects and that reproductive options and fertility preservation have been discussed; identifies and excludes other possible causes; assesses mental health and physical conditions that could negatively impact outcome and discusses risks and benefits.
    Hormone therapy duration: At least 12 months of gender-affirming hormone therapy (or longer if required to achieve the desired surgical result) is required for gender-affirming procedures unless hormone therapy is not desired or is medically contraindicated.>= 12 months hormone therapy unless not desired or contraindicated

    The hormone requirement does not apply to gender-affirming mastectomy.

    Covered Procedures (Adults) - Breast/Chest/Genital/Reconstructive/Adjunctive

    When benefits are provided under the member's contract and eligibility criteria are met, the following procedures may be considered covered:

    Primary breast/chest and genital procedures (adults): Augmentation mammoplasty; breast reduction; breast prosthesis/implant; clitoroplasty; coloproctostomy; colovaginoplasty; colpectomy; electrolysis of grafted tissue; flaps/grafts/tissue transfer directly related to genital reconstruction; glansplasty; hysterectomy; labiaplasty; laser hair removal of grafted tissue; mastectomy; mastopexy; metoidioplasty; nipple reconstruction; oophorectomy; orchiectomy; penectomy; phalloplasty*; placement of penile prosthesis; placement of testicular prosthesis; salpingo-oophorectomy; scrotoplasty; tattooing for nipple and phallus reconstruction; vaginectomy; vaginoplasty; vulvoplasty; urethroplasty.

    Phalloplasty is marked with an asterisk in the policy.

    Additional reconstructive and adjunctive procedures (adults): Abdominoplasty; blepharoplasty; Botox injections; brow lift/augmentation/reduction; calf implants; cheek/malar implants; chin contouring/genioplasty; collagen injections; cranial prosthesis (wig); face lift; forehead reduction/contouring; facial bone reduction/osteoplasty; flaps/grafts/tissue transfer related to covered procedure; frontal sinus remodeling; gluteal augmentation; hair removal (electrolysis/laser); hair transplantation/hairline advancement; hip implants; jaw reduction/contouring/augmentation; laryngoplasty/chondrolaryngoplasty/tracheal shave; lip lift/filling/augmentation; male chest reconstruction/pectoral implants; monsplasty/mons reduction; orbital reconstruction; panniculectomy; repair of introitus; rhinoplasty; skin resurfacing; suction-assisted lipoplasty/lipofilling/fat grafting; thyroid chondroplasty; voice modification and concurrent speech therapy; and other listed adjunctive procedures.

    Adolescent Coverage Note

    Certain procedures for adolescents may be considered on a case-by-case basis

    Adolescent case-by-case coverage: Chest/breast/genital reconstructive and adjunctive procedures (with the exception of phalloplasty) may be considered for adolescent members on a case-by-case basis when the adolescent eligibility criteria and comprehensive biopsychosocial assessment demonstrate readiness for the proposed treatment/procedure.case-by-case

    Phalloplasty is an exception and is not considered for adolescents.

    Medical necessity and multidisciplinary determination

    Covered when clinical and multidisciplinary criteria are met per referenced guidelines

    Multidisciplinary determination: Gender-affirming medical and surgical treatments may be considered medically necessary for appropriately selected transgender and gender-diverse individuals when supported by qualified clinicians and multidisciplinary assessment per WPATH SOC-8 and Endocrine Society guidance.

    Guidance emphasizes interdisciplinary coordination, collaboration between mental health, endocrine, primary care and surgical teams, and multidisciplinary assessment especially for adolescents and genital surgery.

    Clinical evidence basis: The policy recognizes evidence demonstrating benefit of gender-affirming surgery on postoperative outcomes (well-being, sexual function, satisfaction) in adults and cites growing but limited evidence in youth; timing for more irreversible or complex procedures should consider age, maturity, and multidisciplinary consensus.

    Adolescent criteria

    Adolescent care considerations

    Adolescent eligibility considerations: A comprehensive biopsychosocial assessment by licensed mental health and medical professionals is recommended for adolescents; genital surgeries involving gonadectomy and/or hysterectomy are generally delayed until age 18 or the legal age of majority in the individual's country, while timing of chest/breast surgery is determined case-by-case based on physical and mental health status.

    WPATH SOC-8 and Endocrine Society recommendations cited; phalloplasty is not recommended for youth under 18 due to complexity and high complication rates.

    Unless the member's contract specifically provides otherwise, Johns Hopkins Health Plans considers certain gender-affirming procedures to be cosmetic and not medically necessary. These expressly include: revision or repeat adjunctive surgery intended solely to perfect appearance, and any surgery or procedure performed for the purpose of reversing the appearance of normal aging. (See exclusions; benefits apply only if the member’s SPD/contract provides coverage.)

    The policy identifies a small set of procedures regarded as investigational/experimental and not covered unless the member’s contract specifically provides benefits. Examples listed are uterine transplantation and penile transplantation, which the plan states do not meet its Technology Evaluation Criteria (TEC) unless otherwise specified in the member’s benefits.

    The policy references WPATH SOC-8 and pediatric evidence when discussing adolescent surgical care and notes that, given the high complexity and elevated complication rates of phalloplasty compared with other gender-affirming surgeries, phalloplasty is not recommended in youth under 18. This reflects concerns about irreversibility, technical complexity, and the need for additional cognitive and emotional maturation prior to consideration of procedures with substantial risk.

    Portions of the document excerpt enumerate numerous CPT codes associated with gender-affirming, reconstructive, and adjunctive procedures but do not, in those sections, provide standalone determinations of medical necessity or explicit criteria tied to each code. The listed CPT groups (e.g., dermatologic/adjunctive codes, craniofacial/ nasal codes, and genital reconstruction/urologic codes) are presented as examples and cross-references within the policy text; coverage remains contingent on meeting the policy’s diagnostic and procedural eligibility requirements and the member’s specific benefit plan.

    The policy includes a set of HCPCS codes (e.g., A9282, C1813, C2622, G0429, L8600) that are provided for informational purposes only. Their inclusion in the code list does not, by itself, indicate whether the services described are covered; benefit determination depends on the member’s specific SPD and applicable coverage rules.

    This revision notes no changes to the policy criteria. The Summary of Changes indicates the substantive coverage criteria and exclusions remain as in the prior policy; only administrative elements (such as approval statements or table formatting) were modified in this update.

    The policy explicitly states that revision/repeat adjunctive surgeries intended to perfect appearance and procedures aimed at reversing normal aging are considered cosmetic and therefore not medically necessary unless the member’s contract specifically provides coverage for those services. This exclusion aligns with the document’s general approach that cosmetic-intent procedures are not covered absent contractual benefit.

    The policy includes a coding disclaimer clarifying that the inclusion of CPT and HCPCS codes in the document is informational only and does not imply coverage or guarantee reimbursement. Benefit determination is made based on the member’s specific benefit plan document (SPD) and applicable laws; inpatient admissions and other services may require preauthorization per plan rules.

    Coding: CPT, HCPCS and Diagnosis Codes

    CPT examples (informational)CPT
    11442Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 1.1 to 2.0 cm
    CPT examples (informational continued)CPT
    11446Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 4.0 cm
    11920Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or less
    11921Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cm
    11950Subcutaneous injection of filling material (eg, collagen); 1 cc or less
    11951Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc
    11952Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc
    11954Subcutaneous injection of filling material (eg, collagen); over 10.0 cc
    11960Insertion of tissue expander(s) for other than breast, including subsequent expansion
    11970Replacement of tissue expander with permanent implant
    11971Removal of tissue expander without insertion of implant
    1–10 of 14
    1/2
    CPT examples (additional)CPT
    15734Muscle, myocutaneous, or fasciocutaneous flap; trunk
    15769Grafting of autologous soft tissue, other, harvested by direct excision (eg, fat, dermis, fascia)
    15771Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate
    15772Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; each additional 50 cc injectate, or part thereof (List separately in addition to code for primary procedure)
    15773Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; 25 cc or less injectate
    15774Grafting of autologous fat; each additional 25 cc injectate, or part thereof (List separately in addition to code for primary procedure)
    15775Punch graft for hair transplant; 1 to 15 punch grafts
    15776Punch graft for hair transplant; more than 15 punch grafts
    15780Dermabrasion; total face (eg, for acne scarring, fine wrinkling, rhytids, general keratosis)
    15781Dermabrasion; segmental, face
    1–10 of 11
    1/2
    Listed surgical and dermatologic CPT codesCPT
    15789Chemical peel, facial; dermal
    15792Chemical peel, nonfacial; epidermal
    15793Chemical peel, nonfacial; dermal
    15820Blepharoplasty, lower eyelid
    15821Blepharoplasty, lower eyelid; with extensive herniated fat pad
    15822Blepharoplasty, upper eyelid
    15823Blepharoplasty, upper eyelid; with excessive skin weighting down lid
    15824Rhytidectomy; forehead
    15825Rhytidectomy; neck with platysmal tightening (platysmal flap, P-flap)
    15826Rhytidectomy; glabellar frown lines
    1–10 of 35
    1/4
    Craniofacial, nasal, and related surgical CPT codesCPT
    21122Genioplasty; sliding osteotomy, single piece
    21137Genioplasty; sliding osteotomies, 2 or more osteotomies (eg, wedge excision or bone wedge reversal for asymmetrical chin)
    21188Reconstruction midface, osteotomies (other than LeFort type) and bone grafts (includes obtaining autografts)
    21209Osteoplasty, facial bones; reduction
    21210Graft, bone; nasal, maxillary or malar areas (includes obtaining graft)
    21270Malar augmentation, prosthetic material
    30400Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip
    30420Rhinoplasty, primary; including major septal repair
    30430Rhinoplasty, secondary; minor revision
    30435Rhinoplasty, secondary; intermediate revision (bony work with osteotomies)
    1–10 of 16
    1/2
    Genital reconstruction and urologic CPT codesCPT
    53430Urethroplasty, 1-stage reconstruction of male anterior urethra = Urethroplasty, reconstruction of female urethra
    54125Amputation of penis; complete
    54400Insertion of penile prosthesis; non inflatable (semi-rigid)
    54401Insertion of penile prosthesis; inflatable (self-contained)
    54405Insertion of multi-component, inflatable penile prosthesis, including placement of pump, cylinders, and reservoir
    54406Removal of all components of a multi-component, inflatable penile prosthesis without replacement of prosthesis
    54410Removal and replacement of all component(s) of a multi-component, inflatable penile prosthesis at the same operative session
    54660Insertion of testicular prosthesis (separate procedure)
    54690Laparoscopy, surgical; orchiectomy
    55175Scrotoplasty; simple
    1–10 of 24
    1/3
    HCPCS codes (informational)HCPCS
    A9282Wig, any type, each
    C1813Prosthesis, penile, inflatable
    C2622Prosthesis, penile, noninflatable
    G0429Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (LDS) (e.g., as a result of highly active antiretroviral therapy)
    L8600Implantable breast prosthesis, silicone or equal
    Covered CPT codes / procedural codesCPTCovered
    57335Vaginoplasty for intersex state
    58150Total abdominal hysterectomy (corpus and cervix), with or without removal of tube(s), with or without removal of ovary(s)
    58180Supracervical abdominal hysterectomy (subtotal hysterectomy), with or without removal of tube(s), with or without removal of ovary(s)
    58260Vaginal hysterectomy, for uterus 250 g or less
    58262Vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s)
    58275Vaginal hysterectomy, with total or partial vaginectomy
    58290Vaginal hysterectomy, for uterus greater than 250 g
    58291Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s)
    58541Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less
    58542Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s)
    1–10 of 26
    1/3
    ICD-10 codes (informational)ICD-10
    F64.0Transsexualism
    F64.2Gender identity disorder in childhood
    F64.8Other gender identity disorders
    F64.9Gender identity disorder, unspecified
    Z87.890Personal history of sex reassignment

    Provider Actions, Authorization & Documentation

    Prior Authorization

    Prior authorization required

    Prior authorization is required per the member's contract for gender-affirming surgical procedures; approval is contingent on meeting the diagnostic and procedure-specific criteria set forth in the policy (Procedure Number CMS24.08).

    • Obtain prior authorization according to the member's SPD and the plan's authorization process before scheduling gender-affirming surgery.
    • Authorization decisions depend on documented fulfillment of the policy’s diagnostic and surgical eligibility criteria.
    Prior Authorization

    Inpatient preauthorization required

    All inpatient admissions require preauthorization; failure to obtain required preauthorization for an inpatient admission may result in denial or further review per plan rules.

    • Verify inpatient authorization requirements with the member's specific SPD before admission.
    • Obtain and document preauthorization prior to inpatient procedures when the service will be an inpatient stay.
    Note

    Policy identification (CMS24.08); no explicit PA steps in excerpt

    The policy is identified as Procedure Number CMS24.08 with approval and effective dates listed; the excerpt does not describe step-by-step prior authorization submission procedures.

    • Policy identifier: CMS24.08. Approval Date: 01/20/2026. Effective Date: 04/01/2026.
    • Follow plan-specific prior authorization submission processes (not detailed in this excerpt).
    Prior Authorization

    Prior authorization implied for listed CPT codes

    The policy enumerates select CPT procedure codes for gender-affirming surgeries and related procedures; prior authorization is implied for these listed procedures and should be obtained per plan requirements.

    • Examples of listed CPT codes appear in the coding sections (see policy code tables for full lists).
    • Obtain prior authorization when billing any of the enumerated CPT codes for gender-affirming services under the member's plan.
    Prior Authorization

    Policy approval and follow plan PA processes

    This policy was approved by MPAC and becomes effective 04/01/2026; providers should follow the policy and the member’s plan documents for prior authorization and approval processes.

    • Approval: MPAC (01/20/2026); Effective: 04/01/2026.
    • Follow the plan’s authorization processes and SPD language when submitting requests for approval.
    Note

    Pharmacy and hormone coverage — consult formularies

    Consult plan pharmacy formularies and the member's SPD for coverage and any plan-specific requirements for puberty suppression and gender-affirming hormone therapy.

    • Pharmacy/formulary coverage and any utilization management requirements (e.g., prior authorization) are determined by the plan formulary referenced in Section III.
    Documentation Required

    Document collaborative multidisciplinary agreement before surgery

    Before referral for genital gender-affirming surgery, obtain collaborative documentation showing agreement between the mental health professional and the clinician responsible for endocrine therapy that surgery is medically necessary.

    • WPATH and Endocrine Society guidance recommend that the mental health professional and the clinician responsible for endocrine treatment agree that genital surgery is medically necessary prior to referral.
    • Document multidisciplinary collaboration (mental health, endocrine, surgical) especially for adolescent referrals.
    Step Therapy

    No step therapy rules in excerpt

    No step therapy rules for gender-affirming treatments or medications are detailed in the provided excerpt.

    • The policy does not specify step therapy requirements in the shown sections; review the full policy or plan documents for any plan-specific pharmacy management rules.
    Note

    Coding and documentation note — excerpt lists codes but not templates

    The document lists CPT/HCPCS codes and policy header information but this excerpt does not include specific additional documentation templates or forms beyond the letter of medical necessity requirements.

    • Coding disclaimer: inclusion of codes is informational and does not itself indicate coverage; benefits are determined by the member's SPD.
    • Adherence may be monitored via post-payment review or audits.
    Documentation Required

    Required documentation: referral / letter of medical necessity

    A referral/letter of medical necessity from a qualified licensed healthcare professional is required and must document that the member meets diagnostic criteria, that gender dysphoria/incongruence is marked and sustained, capacity for informed consent, understanding of reproductive effects and fertility options, exclusion of other causes, and assessment of coexisting mental/physical conditions.

    • For adults, letters must also document duration and, for gonadectomy, six months of hormone therapy unless hormone therapy is not desired or is medically contraindicated.
    • For adolescents, a comprehensive biopsychosocial assessment by qualified mental health and medical professionals is required and the letter must address capacity, maturity, and fertility counseling.
    Documentation Required

    Multidisciplinary documentation recommended

    Clinical determinations should be made by qualified professionals and multidisciplinary documentation (mental health, endocrine, surgical team) is recommended, particularly for adolescents and for genital surgeries.

    • WPATH SOC-8 and Endocrine Society guidelines are referenced as the clinical guidance supporting multidisciplinary assessment.
    • In adolescents, an expert multidisciplinary team is endorsed; in its absence, recommended collaboration between pediatric endocrinologist, mental health professional, and other providers.
    Documentation Required

    Excerpt lacks further documentation detail

    This excerpt primarily lists procedure codes and policy header information and does not contain additional documentation requirements beyond those for letters of medical necessity and multidisciplinary assessment.

    • Refer to the full policy for any additional forms, checklists, or required supporting clinical records.
    Billing Rule

    Include ICD-10 gender identity codes with requests/claims

    Use the listed ICD-10 diagnosis codes related to gender identity (F64.0, F64.2, F64.8, F64.9) and Z87.890 (personal history of sex reassignment) as supporting diagnosis codes when submitting authorization requests and claims.

    • These ICD-10 codes are provided for informational purposes and are expected to accompany claims and documentation for gender-affirming procedures.
    Documentation Required

    Cite supporting clinical references in documentation

    References and clinical literature (e.g., WPATH SOC-8, Endocrine Society guideline, UpToDate chapters, systematic reviews) are cited in the policy and should be used to support clinical rationale in authorization documentation.

    • Cite WPATH SOC-8 and Endocrine Society guidance when clinical assessments reference standard-of-care recommendations.
    • Include relevant literature citations in complex or case-by-case authorization requests as appropriate.
    Billing Rule

    Pharmacy/medication coverage — check plan formulary

    For puberty suppression and gender-affirming hormone coverage, consult the plan’s pharmacy formulary and SPD for any medication authorization or utilization management requirements.

    • Pharmacy coverage details (including prior authorization) are determined by Employer Health Programs formulary guidance referenced in Section III.
    Documentation Required

    Document collaborative care before surgical referral

    Prior to surgical referral, ensure documented collaboration and agreement between mental health and endocrine clinicians that surgery is appropriate and that risks, timing, and hormone management are addressed.

    • Document that the clinician responsible for endocrine treatment and the mental health professional both concur surgery is medically necessary for genital procedures.
    • For adolescents, ensure documentation of multidisciplinary team input or documented collaboration per WPATH SOC-8.
    Step Therapy

    No step therapy rules provided

    The policy excerpt contains no step therapy requirements or sequencing rules for gender-affirming medications or interventions.

    • If step therapy or other pharmacy management rules are suspected, verify in the full policy or the member’s SPD/formulary.
    Denial Risk

    Coding mismatch risk — match billed codes to policy lists

    Ensure procedural coding matches the listed CPT/HCPCS codes in the policy; miscoding of procedures such as hysterectomy, vaginectomy, oophorectomy, or urethroplasty may lead to claim denials or processing issues.

    • Use the policy’s coding tables when assigning CPT/HCPCS codes to gender-affirming surgical claims.
    • Be aware the coding disclaimer states inclusion of codes is informational and benefit coverage is determined by the member’s SPD.
    Note

    No changes to policy criteria

    There are no changes to the policy criteria in the current revision; authorization criteria remain as previously stated.

    • Revision history (01/20/2026) notes: 'No changes to policy criteria.'

    Background and Scope

    Gender-affirming treatments described in the policy are provided when a qualified clinician establishes a diagnosis of Gender Dysphoria per DSM-5-TR criteria and when multidisciplinary assessment supports treatment. The background notes that evidence supports benefits of gender-affirming surgery for appropriately selected individuals and references WPATH SOC-8 as a primary guidance source for clinical decision-making and the need for multidisciplinary collaboration.

    Definitions and Key Terms

    Adolescents — Definition
    Adolescent age range (policy-specific)For this policy, adolescents are those between the start of puberty (Tanner stage 2) and 18 years old.
    AAP referenceAAP defines adolescents as ages 11–21 (early 11–14, middle 15–17, late 18–21) but policy uses puberty onset to 18.
    Biopsychosocial assessment noteThe policy emphasizes that age boundaries are imprecise and treatment planning is based on comprehensive biopsychosocial assessment.
    Gender Dysphoria / Gender Incongruence — Definitions and distinctions
    Gender Dysphoria (DSM-5-TR)State of clinically significant distress or impairment related to a mismatch between experienced/expressed gender and sex assigned at birth; diagnosis per DSM-5-TR criteria (manifested for ≥6 months with at least two indicators).
    Gender Incongruence (ICD-11)ICD-11 term describing a marked and persistent incompatibility between a person’s gender identity and the gender expected based on birth-assigned sex; considered a sexual health–related condition (not a mental disorder).
    Distinction notePolicy notes DSM-5-TR retains gender dysphoria as a mental health diagnosis for clinical use in the U.S., while ICD-11 uses gender incongruence terminology and reframes classification away from mental disorder.
    Gender-Affirming Surgery — Definition
    DefinitionSurgical procedures performed to change primary and/or secondary sex characteristics to affirm a person’s gender identity.
    Scope examples (policy context)Includes breast/chest, genital, and reconstructive/adjunctive procedures intended to align physical characteristics with gender identity.
    Source guidanceDefinition referenced to WPATH Standards of Care (WPATH, 2022) as the clinical context for such procedures.
    Gender Diverse — Definition
    DefinitionPeople with gender identities and/or expressions that differ from social and cultural expectations attributed to their sex assigned at birth; may include nonbinary, gender expansive, and gender nonconforming individuals.
    Examples of expressionGender expression may include dress, hairstyle, accessories, cosmetics, hormonal and surgical interventions, mannerisms, speech, and names.
    Clinical referenceTerm and definition referenced to WPATH (2022) within the policy.
    Gender Dysphoria / Gender Incongruence — Additional phrasing
    Alternate phrasing (gender dysphoria)Gender dysphoria is described as distress or discomfort experienced because a person’s gender identity differs from that physically and/or socially attributed to their sex assigned at birth.
    Alternate phrasing (gender incongruence)Gender incongruence (ICD-11) describes a marked and persistent experience of incompatibility between gender identity and birth-assigned sex, reframed as a condition related to sexual health rather than a mental disorder.
    Clinical implicationNot all transgender and gender-diverse people experience gender dysphoria; clinical diagnosis requires assessment of clinically significant distress if present.
    Transition — Definition
    DefinitionTransition is the process of changing an individual’s gender expression associated with their assigned sex at birth to one that better matches their gender identity; may include social, hormonal, and surgical steps.
    Social stepsMay include changing name, pronouns, clothing, hairstyles, and other social markers of gender.
    Medical/legal stepsMay include hormone therapy and surgical procedures, and legal changes (e.g., name/gender marker changes) as part of aligning gender expression with identity.
    Tanner Stages — Pubertal development staging
    PurposeTanner stages describe pubertal development (breast and genital stages) used to guide timing of gender-affirming interventions.
    Breast development stagesStage 1 prepubertal; Stage 2 breast/papilla elevated as small mound; Stage 3 breast and areola enlarged; Stage 4 areola forms secondary mound; Stage 5 mature adult breast configuration.
    Genital development stagesStage 1 prepubertal (testicular volume <4 mL); Stage 2 slight enlargement of penis and scrotal changes; Stage 3 penis longer, testes 8–12 mL; Stage 4 further enlargement, testes 12–15 mL; Stage 5 adult size, testicular volume >15 mL.
    Retransition — Definition
    DefinitionRetransition refers to a second or subsequent gender transition by social, medical, or legal means; individuals may retransition more than once and for many reasons (evolving identity, health, social, or financial concerns).
    Clinical noteRetransition may involve shifts between binary and nonbinary identities and can be motivated by a range of personal or contextual factors.
    ReferenceTerm and context cited to WPATH (2022) in the policy definitions.
    Informational ICD-10 diagnosis codes
    ICD-10 codes (informational)F64.0 Transsexualism; F64.2 Gender identity disorder in childhood; F64.8 Other gender identity disorders; F64.9 Gender identity disorder, unspecified; Z87.890 Personal history of sex reassignment.
    Usage noteICD-10 codes provided for informational purposes only and are expected to accompany claims for gender-affirming procedures when appropriate.
    Policy disclaimerIn policy text the ICD-10 list is explicitly labeled 'FOR INFORMATIONAL PURPOSES ONLY.'
    WPATH SOC v8 — Reference
    Reference documentWPATH Standards of Care (Version 8) referenced as a primary clinical guidance document for transgender and gender-diverse health care in the policy.
    Role in policySOC-8 is cited throughout for recommendations on assessment, multidisciplinary care, and adolescent considerations.
    Citation detailsWPATH (2022). Standards of Care for the Health of Transgender, and Gender-Diverse People. Version 8.

    Revision History

    2026-01-20Approval

    Policy approved by the Medical Policy Advisory Committee (MPAC); signature on file.

    2026-04-01Effective dateLatest

    Policy becomes effective and supersedes the prior version dated 2025-04-01.

    2025-04-01Superseded

    Previous version of this policy (superseded by the 2026 revision) noted as the superseded date in the document header.

    The Summary of Changes for the 01/20/2026 revision states there were no changes to policy criteria. This indicates that the existing eligibility requirements, exclusions, and coverage logic remain in force for this version; administrative or presentation elements may have been updated but criteria were unchanged.